BP
GSK icon

Banyan Partners’s GSK GSK Stock Holding History

Banyan Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$401K Sell
6,985
-2,004
-22% -$123K 0.03% 333
2014
Q2 		$601K Sell
8,989
-4,729
-34% -$320K 0.05% 292
2014
Q1 		$916K Buy
13,718
+6,489
+90% +$439K 0.08% 230
2013
Q4 		$482K Buy
+7,229
New +$469K 0.03% 312

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Banyan Partners's GSK Position: Q3 2014 in Review

Banyan Partners reduced its GSK (GSK) stake by 22% in Q3 2014, selling an estimated $123K and leaving 6,985 shares worth $401K. The position accounts for 0.03% of the portfolio, ranked #333.

Banyan Partners first reported a position in GSK in Q4 2013 and has held it in 4 quarters since. The position peaked at $916K in Q1 2014. 701 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

  • Banyan Partners held 6,985 shares of GSK worth $401K as of Q3 2014.
  • Banyan Partners sold 2,004 GSK shares in Q3 2014, an estimated $123K.
  • GSK made up 0.03% of Banyan Partners's portfolio in Q3 2014, its #333 holding.
  • Banyan Partners first reported a position in GSK in Q4 2013 and has held it in 4 quarters since.
  • Banyan Partners's GSK position peaked at $916K in Q1 2014.
  • 701 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Banyan Partners's 13F filing for Q3 2014, filed 14 Nov 2014.